| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 747 | 992 | 492 | 367 | | Cost of Revenue | 1,799 | 2,113 | 1,644 | 709 | | | Gross Profit | (1,052) | (1,121) | (1,152) | (342) | | | Operating Expenses | | Research Development | 88 | 12 | 167 | 74 | | Selling General and Administrative | 1,898 | 2,186 | 1,990 | 2,494 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 427 | 707 | 108 | 251 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,464) | (4,025) | (3,418) | (3,161) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (227) | 2,938 | 1,422 | 239 | | Earnings Before Interest And Taxes | (3,691) | (1,087) | (1,996) | (2,922) | | Interest Expense | 1,120 | 2,123 | 1,907 | 1,664 | | Income Before Tax | (4,810) | (3,210) | (3,903) | (4,586) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,810) | (3,210) | (3,903) | (4,586) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (4,810) | (3,210) | (3,903) | (4,586) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($4,810) | ($3,210) | ($3,903) | ($4,586) |
|
0.26% Nasdaq 0.00%
Income Statement
